Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of abcd1-deficient mice.
Cellular senescence and the aging brain.
Age-related changes in spleen of Dark Agouti rats immunized for experimental autoimmune encephalomyelitis.
Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation.
Treatment Issues in Multiple Sclerosis in Latin America.
Hesperidin, a Citrus Flavonoid, Has the Ameliorative Effects Against Experimental Autoimmune Encephalomyelitis (EAE) in a C57BL/J6 Mouse Model.
Differential Diagnosis for Multiple Sclerosis-related Optic Neuritis.
Brugada sign in a multiple sclerosis patient: Relation to autonomic nervous system dysfunction and therapeutic dilemmas.
Fbxw7 Limits Myelination by Inhibiting mTOR Signaling.
Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination.
Screening, Synthesis, and In Vitro Evaluation of Vinyl Sulfones as Inhibitors of Complement-Dependent Cytotoxicity in Neuromyelitis Optica.
Epidemiology and clinical record of multiple sclerosis in selected countries - a systematic review.
TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review.
Implementing technology-based embedded assessment in the home and community life of individuals aging with disabilities: a participatory research and development study.
Immunomodulatory activity of polysaccharides isolated from Clerodendrum splendens: Beneficial effects in experimental autoimmune encephalomyelitis.
Quantifying gait impairment using an instrumented treadmill in people with multiple sclerosis.
Segmented corpus callosum diffusivity correlates with the Expanded Disability Status Scale score in the early stages of relapsing-remitting multiple sclerosis.
DTI detects water diffusion abnormalities in the thalamus that correlate with an extremity pain episode in a patient with multiple sclerosis.
Voxel-Wise Displacement as Independent Features in Classification of Multiple Sclerosis.
Validity of Minimal Clinically Important Difference Values for the Multiple Sclerosis Walking Scale-12?
Validation of the automated method VIENA: An accurate, precise, and robust measure of ventricular enlargement.
Ocular and cervical vestibular evoked myogenic potentials in patients with multiple sclerosis.
[The experience of using fingolimod (gilenya) in patients with relapsing-remitting multiple sclerosis.]
Timed 25-Foot Walk: Direct evidence that improving 20% or greater is clinically meaningful in MS.
Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS.

Pages